Cargando…

Novel Therapeutics for Anthracycline Induced Cardiotoxicity

Anthracyclines remain an essential component of the treatment of many hematologic and solid organ malignancies, but has important implications on cardiovascular disease. Anthracycline induced cardiotoxicity (AIC) ranges from asymptomatic LV dysfunction to highly morbid end- stage heart failure. As c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuong, Jacqueline T., Stein-Merlob, Ashley F., Cheng, Richard K., Yang, Eric H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072636/ https://www.ncbi.nlm.nih.gov/pubmed/35528842 http://dx.doi.org/10.3389/fcvm.2022.863314

Ejemplares similares

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity
por: Packard, René R. Sevag, et al.
Publicado: (2023)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Genetics of Anthracycline-Associated Cardiotoxicity
por: Al-Otaibi, Talal Khalid, et al.
Publicado: (2022)

Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
por: Feher, Attila, et al.
Publicado: (2022)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
por: Murabito, Alessandra, et al.
Publicado: (2020)

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
por: Moossavi, Maryam, et al.
Publicado: (2023)

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
por: Kang, Dong-Woo, et al.
Publicado: (2022)

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2022)

Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments
por: Zhang, Guoxia, et al.
Publicado: (2022)

Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging
por: Jong, Jeremy, et al.
Publicado: (2022)

Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
por: He, Dongsheng, et al.
Publicado: (2022)

Red Blood Cell Distribution Width Is a Predictive Factor of Anthracycline-Induced Cardiotoxicity
por: Yaegashi, Daiki, et al.
Publicado: (2020)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
por: Kluck, George E. G., et al.
Publicado: (2020)

Cardiotoxicity of Anticancer Therapeutics
por: Dong, Jerry, et al.
Publicado: (2018)

Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach
por: Rao, Yifei, et al.
Publicado: (2023)

A global case meta-analysis of three-dimensional speckle tracking for evaluating the cardiotoxicity of anthracycline chemotherapy in breast cancer
por: Zhang, Li, et al.
Publicado: (2022)

Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis
por: Jin, Hao, et al.
Publicado: (2023)

Early Change in Area Strain Detected by 3D Speckle Tracking Is Associated With Subsequent Cardiotoxicity in Patients Treated With Low Doses of Anthracyclines
por: Piveta, Rafael B., et al.
Publicado: (2022)

Anthracycline-induced cardiotoxicity and senescence
por: Booth, Laura K., et al.
Publicado: (2022)

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death
por: Antoniak, Silvio, et al.
Publicado: (2022)

Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies
por: Stein-Merlob, Ashley F., et al.
Publicado: (2021)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)

Emerging roles of circular RNAs in cancer therapy-induced cardiotoxicity
por: Cheng, Ziji, et al.
Publicado: (2023)

Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
por: Qian, Hongyan, et al.
Publicado: (2023)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging
por: Podlesnikar, Tomaž, et al.
Publicado: (2022)

Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future
por: Li, Mo-Yun, et al.
Publicado: (2022)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
por: Kumari, Himani, et al.
Publicado: (2020)

Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020)

Advances in Cardiotoxicity Induced by Altered Mitochondrial Dynamics and Mitophagy
por: Yin, Yiyuan, et al.
Publicado: (2021)

Preventive strategies of cancer therapeutics-related cardiotoxicity in childhood cancer survivors: a protocol of systematic review
por: Zhang, Xin-Yu, et al.
Publicado: (2022)

The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity
por: Ibanez, Borja, et al.
Publicado: (2022)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
por: Chung, Woo-Baek, et al.
Publicado: (2016)

Anthracycline-Induced Cardiotoxicity: Remembering the Forgotten Ventricle
por: Liu, Jennifer E.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5fmm8dfd2venvbq2n4kf2ei0im